The Chinese Society for Immunology (CSI), a voluntary, national, academic, non-profit and non-governmental organization, formed from the national scientific and technical immunologists, is registered and established in accordance with the laws of China. CSI has grown out of the Chinese Committee for Immunology, which was founded in 1984, and became a member of the International Union of Immunological Societies (IUIS) in the same year. The formal proceedings to establish CSI began in 1988 after it was approved and affiliated with the China Association for Science and Technology. In 1992, CSI became a member of The Federation of Immunological Societies of Asia-Oceania (FIMSA). Currently, the society possesses over 10000 members and 3500 members belong to the IUIS.

President
Yuzhang Wu, MD, PhD

Secretary-General
Xuetao Cao, MD, PhD

 
Official Journal of CSI

International Meetings of Interest


The 9th International γδ T cell Conference
(June 18 - 21, 2021, Beijing, China)

News


Dr. Xindong Liu’s team provides SOSTDC1-producing follicular helper T cells promote regulatory follicular T cell differentiation

Dr. Yuxia Zhang’s team provides comprehensive liver immune profiling in infants with biliary atresia and proposes B-cell-modifying therapies to alleviate liver pathology

Dr. Xuetao Cao’s group identifies a novel lncRNA which promotes antiviral innate immunity

The Investigation of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity by NIFDC researchers published in Cell

WANG Honglin’s group revealed the presence of "autoantigens" in the epidermal keratinocytes of patients with psoriasis and provided a new treatment strategy

Dr. Chenqi Xu’s group developed a new strategy of CAR-T cell therapy

Dr. Haopeng Wang’s group at ShanghaiTech University developed a novel CAR-T therapy

MAbs against COVID-19 Developed by IMCAS Researchers published in NATURE

HUI XIAO’s group at Institut Pasteur of Shanghai found a new mechanism for cGAMP cell-to-cell transmission and STING activation during viral infection

Dr. Wei Zhao’s group reveals that redox homeostasis maintained by GPX4 facilitates STING activation

Dr. Feng Shao’s group reveals that granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells

Dr. Su’s Group Demonstrates that Complement Signals Determine Opposite Effects of B Cells in Tumors

Dr Qing Zhou’s team reveals that non-cleavable variants of RIPK1 cause a new dominant autoinflammatory disease

Dr. Junyu Xiao’s group provided critical insights into the assembly and secretion of human IgM and IgA

Dr. Yuxin Yin’s group discovered a novel mechanism of tumor immune escape